IMC Chicago
ABVX

IMC Chicago’s Abivax ABVX Stock Holding History

IMC Chicago’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Sell
87,392
-18,751
-18% -$2.12M ﹤0.01% 1438
2026
Q1 		$11.8M Buy
106,143
+89,624
+543% +$10.6M ﹤0.01% 1152
2025
Q4 		$2.23M Buy
+16,519
New +$1.8M ﹤0.01% 2321

Other funds holding ABVX

NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

IMC Chicago's ABVX Position: Q2 2026 in Review

IMC Chicago reduced its Abivax (ABVX) stake by 18% in Q2 2026, selling an estimated $2.12M and leaving 87,392 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

IMC Chicago first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.8M in Q1 2026. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • IMC Chicago held 87,392 shares of Abivax worth $11.6M as of Q2 2026.
  • IMC Chicago sold 18,751 Abivax shares in Q2 2026, an estimated $2.12M.
  • Abivax made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1438 holding.
  • IMC Chicago first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • IMC Chicago's Abivax position peaked at $11.8M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.